breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) aged 18 to 70 years old; (2) according to the clinical/pathological staging was diagnosed as I~III stage breast cancer; (3) sign informed consent; (4) proposed A/ EC-T 3-week adjuvant/neoadjuvant chemotherapy program; (5) the breast specialist agrees to conduct the study after evaluating the patient.
Exclusion criteria
Exclusion criteria: (1) combined with other tumors; (2) suffering from the diabetes or peripheral neuropathy; (3) suffering from mental, psychological, immune system diseases, serious digestive system diseases and other diseases affecting treatment and evaluation of curative effect; (4) serious coagulation dysfunction; (5) there are serious skin disorders in the acupuncture area; (6) has not received Chinese medicine or acupuncture treatment in the past 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Standard table for grading of nausea and vomiting caused by chemotherapy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient-Generated Subjective Global Assessment;National Cancer Institute-Common Toxicity Criteria for Adverse Events (NCI-CTCAE), version 4.0;Neuropathic Pain Scale;brief pain inventory;average daily number of hot flashes; | — |
Countries
China
Contacts
First Affiliated Hospital of Nanjing Medical University, Jiangsu Privnce Hospital